General anxiety was measured using the anxiety subscale of the Hospital Anxiety and Depression Scale; this was completed by patients at baseline, on the first and last day of treatment, and 6 weeks after radiotherapy. For the purposes of this analysis, possible (summary score 8-10) and probable (summary score 11 or above) cases of anxiety have been combined (Zigmond and Snaith, 1983) . Analysis was restricted to patients who responded at all 4 assessment points. General estimating equations were used to compare changes in anxiety over the study period.
In the previous trial, 24% of patients were very/quite worried about radiotherapy in general after receipt of the booklet (Eardley, 1988) . It was estimated that 252 subjects were required to detect a reduction in the proportion of very/quite worried patients to 10% in the intervention group for a study power of 80% at the 5% twosided significance level.
352 eligible patients were seen during the study period; 26 were not referred on to the investigator by consultants. Another 29 patients were excluded either because they had already viewed the videotape (n = 25) or the randomization office could not be contacted (n = 4). 23 (15.3%) patients refused to participate: 10 did not want more information, 9 could not wait and 4 did not offer a reason.
The remaining 274 patients were randomized; their mean age was 66 years and 240 (87.6%) were male. 141 patients (51.5%) were allocated VT and 133 (48.5%) WIO. The distribution of baseline characteristics across study groups is shown in Table 1 . 6 patients allocated VT did not receive radiotherapy: 5 were found to have metastatic disease after recruitment. 4 patients failed to receive the correct information package but remained in their allocated group for analysis. 132 (93.6%) patients allocated VT and 132 (99.2%) allocated WIO responded to the question 'How worried are you about radiotherapy in general?' at baseline and on the first day of radiotherapy. 19 (14.4%) patients in the VT group and 20 (15.2%) in the WIO group were very/quite worried about radiotherapy at baseline. On the first day of radiotherapy, this proportion fell in both the VT group (n = 16, 12.1%) and the WIO group (n = 16, 12.1%). The reduction in worry levels from baseline was not significant in either the VT group (Z = -0.63, P = 0.53) or WIO group (Z = -0.77, P = 0.44); nor was the reduction in worry levels Table 2) .
The responses to questions about specific aspects of radiotherapy and proportionate changes in worry levels from baseline are shown in Table 2 . Patients in the WIO group were significantly less worried about hair loss than those in the VT group (Mann Whitney U = 7365.5, P = 0.02).
118 (83.7%) patients allocated VT and 112 (85.5%) allocated WIO completed the anxiety subscale at all assessment points; at baseline, 29 (24.6%) patients in the VT group and 28 (25.0%) in the WIO group were anxious. General anxiety did not decrease in either study group until the last day of treatment but this fall was only maintained 6 weeks after treatment among those allocated the videotape: in the VT group, 30 (25.4%) subjects were anxious on the first day of radiotherapy, 19 (16.1%) on the last day and 18 (15.3%) 6 weeks after treatment; in the WIO group, 28 (25.0%) subjects were anxious on the first day of radiotherapy, 22 (19.6%) on the last day and 28 (25.0%) 6 weeks after treatment. The difference in the change in proportions of anxious subjects over all assessment points was not statistically significant (χ 2 = 3.32, df = 3, P = 0.34).
In this cohort of cancer patients, the provision of information in either written or videotape format did not significantly reduce pretreatment worry. However, the proportion of patients in this study who felt very or quite worried before treatment was lower than that previously reported among patients at the Christie (Eardley, 1988) . This improvement may reflect the ongoing programme of communication skills training for consultants in this hospital. In addition, our study population consisted predominantly of elderly male patients who have fewer concerns and demand less information (Aass et al, 1996; Jones et al, 1999) . It has been argued that older people are less conversant with videotape technology (Thomas et al, 1999 ) but a random sample of 14 patients in the VT group interviewed at the end of the trial had all viewed the videotape. A recent trial of videotape among a more heterogeneous cohort of patients undergoing radiotherapy or chemotherapy suggests that videotape reduces anxiety during treatment (Thomas et al, 2000) . However, patients in this trial who were allocated videotape received more and different information than the control group and therefore the difference in outcome cannot solely be attributed to the medium. Other patient groups have not expressed a preference for audio-visual materials over written information (Coulter et al, 1999) .
Patients receiving written information were significantly less worried about hair loss than those also receiving the videotape (Mann Whitney U = 7365.5, P = 0.02). Re-evaluation of the information materials revealed extensive coverage of this concern in RCT of a radiotherapy videotape 9
British Journal of Cancer (2001) the booklet but no direct reference to it in the videotape. As technology advances and it becomes easier to assemble and disseminate information, it is essential that as much attention is paid to quality as to presentation. General anxiety, like worry about radiotherapy, did not decrease before commencement of treatment but did fall on the last day of treatment. This reduction was only maintained in the post-treatment period among those allocated VT. The absolute difference between study groups 6 weeks after radiotherapy of 9.7% was not significant (χ 2 = 3.41, df = 1, P = 0.065) but this study was not designed to detect a significant difference of this magnitude for this endpoint. The concerns of cancer patients may change over time; following diagnosis, patients may be anxious about their forthcoming treatment but following treatment, they may be most anxious about their prognosis (Butow et al, 1997) . The videotape contained footage of surviving cancer patients and we postulate that these images may provide longer-term reassurance to those more recently diagnosed. Future trials of videotape information should include such longer-term outcome measures.
